FDA To Allow Certain Office-Use Compounding, In Exchange For GMP Oversight
FDA will release guidance within two months green lighting certain office-use compounding, so long as those 503A pharmacies register as 503B ...
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment